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Buerger’s disease, also known as thromboangitis
obliterans, is a rare condition that is characterized
by vascular thrombosis, and which in the past
almost exclusively affected men.
Introduction
We describe a case of Buerger’s in a 43-year-old
female smoker who initially presented with
painful lumps on her limbs misdiagnosed as pan-
niculitis. The case highlights the diagnostic and
therapeutic challenges faced by the multidisci-
plinary team involved in her care, and how a hol-
istic approach has allowed her to maintain her
independence.
Case report
Diagnostic challenge
Our patient is a right-handed 43-year-old unem-
ployed English woman who was seen for the
ﬁrst time in the vascular clinic 14 years ago. She
initially presented to her local hospital in 1992
with a number of painful lumps on her feet and
arms which were diagnosed as panniculitis. She
had a 22-pack-year history having started
smoking at the age of 14. She had no other risk
factors for arterial disease.
She was then referred to a tertiary centre for
rheumatology in 1996 where Buerger’s disease
was clinically suspected. At this time, Buerger’s
was uncommon in women, and to conﬁrm the
diagnosis she underwent a series of further inves-
tigations, to exclude other possible causes, namely
the classical vasculitides.
In August 1997, while undergoing investi-
gations, she complained of a painful right hallux,
which was thought to be due to vasculitis or vaso-
spasm. She was commenced on an iloprost
infusion, but this was unsuccessful in controlling
her symptoms. Over a four-week period, she
developed gangrene in two of her right toes that
necessitated amputation. However, the tissue
loss and pain worsened, and she underwent a
right-sided below-knee amputation. These ampu-
tation specimens histologically conﬁrmed her
diagnosis.
Therapeutic challenge
To date, having undergone atotal of 45 operations,
our patient has bilateral above-knee amputations,
a right mid-forearm amputation, and a non-
dominant left hand with two amputated digits.
A timeline of her operations is shown in Figure 1.
Despite her signiﬁcant physical impairment,
she lives alone in a ground ﬂoor ﬂat which has
been modiﬁed. Our patient has three children,
who are very supportive, helping with her shop-
ping. She is otherwise independent with her
activities of daily living and has no formal care
package. Our patient mobilizes using awheelchair
and drives an adapted car. She is able to perform
her everyday tasks through the provision of pros-
theses by limb-ﬁtting services, rehabilitation pro-
vided by physiotherapists, and the use of special
equipment at home provided for her by occu-
pational therapy. The involvement of the different
members of the multidisciplinary team is sum-
marized in Table 1.
Our patient hasinsight intosmokingasa signiﬁ-
cant contributing factor to the progression of her
Buerger’s disease; however, she has tried to quit
smoking on numerous occasions. The longest
period she has not smoked for has been eight
months in the past 14 years. She has tried support
classes, oral and topical nicotine replacement, and
alternative therapies to no avail.
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1Figure 1
Summary of the operations which our patient has had performed. Other operations include a left femoral endarterectomy,
upper and lower limb nerve blocks and sympathectomies, and nail avulsions
Table 1
The different members of the multidisciplinary team involved in the care of our patient, in chronological order, and commonly
used pharmacological interventions employed in her management. The professions and pharmacotherapeutics highlighted
in italics have been involved with her care and utilized, respectively, on a number of occasions
Profession Involvement in our patient’s care
Rheumatology Initially for the investigation of a vasculitis. Subsequent referrals for treatment and to
re-conﬁrm the diagnosis of Buerger’s disease in 2002 and 2008
Vascular surgery For the assessment of her vasculature and to plan and implement surgical and non-surgical
re-vascularization strategies; also to manage tissue loss
Anaesthetics Preoperative assessment and administration of anaesthesia for operations
Gastroenterology Perform investigations for gastrointestinal symptoms and to exclude inﬂammatory bowel
disease
Vascular scientists Regular duplex ultrasonographic assessment of both arterial and venous systems
Radiology Performing and interpreting angiography and tomographic imaging
Pain team Regular assessment of her pain control postoperatively and during her rehabilitation; this
includes the management of phantom limb syndrome
Limb-ﬁtting services Fittings with prostheses
Physiotherapy and
rehabilitation
Provided her with rehabilitation and exercise plans following her operations; referred her to
occupational therapy for household modiﬁcations
Dermatology Diagnosis of cutaneous manifestations of her Buerger’s disease
Neurology Assessment and management of chronic lumbar back pain
Spinal surgery Review of chronic lumbar pain; advised that no surgical intervention appropriate
Dieticians Regular reviews of her nutritional status, especially during her prolonged admissions
complicated by depression
Psychiatry Assessment of our patient’s low mood
District nurses Help with her postoperative care at home, particularly wound care including removal of
sutures
Occupational therapy Assessed her for and provided her with an electric bath seat, level access shower (uses a
shower wheelchair), kitchen trolleyand ramps; also assessed and lowered cooking surfaces
Social services Provided her with a wheelchair and assisted with mobility issues, including an adapted car
Pharmacotherapeutics Indications
Iloprost infusions Vasodilating prostacyclin analogue
Aspirin Antiplatelet, prior to warfarisisation
Clopidogrel Antiplatelet, prior to warfarisisation
Warfarin Anticoagulant for the prevention of thrombosis and embolization
Cyanocobalamin Vitamin B12 vitamer used to decrease blood homocysteine levels, a risk factor for peripheral
arterial disease
Simvastatin For the lowering of cholesterol and also for its pleotropic effects
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2Discussion
Buerger’s disease, also known as thromboangitis
obliterans, was ﬁrst described over 130 years
ago and later detailed by Leo Buerger through
pathological examination of amputation speci-
mens.
1 It is a rare disease with differing world-
wide prevalence; as low as 0.5% in Western
Europe and as high as 80% in Ashkenazi Jews.
2
Buerger’s disease, once considered a disease
which almost exclusively affected men, is now
increasing in prevalence among women owing to
changing patterns in smoking.
It commonly affects small-to-medium-sized
arteries and veins. The exact pathogenensis is
unknown, however, it has been described to
involve both inherited and prothrombotic factors
leading to intravascular thrombosis.
3 Combined
with the effects of smoking, inﬂammatory inﬁltra-
tion of the vessel wall results.
Diagnosis is made using a number of diagnos-
tic criteria, for example Olin’s criteria, which
includes a patient less than 45 years of age with
present or recent tobacco use.
4 These patients
usually have distal ischaemia, where other
causes such as hypercoagulability have been
excluded.
Long-term outcome with Buerger’s disease
holds an amputation risk of 25% at ﬁve years,
38% at 10 years, and 46% at 20 years.
5 However,
amputation may be avoided, or deferred, by
smoking cessation.
6
This case illustrates the difﬁculties faced in
making certain diagnoses and conveys the vitality
of engaging a multidisciplinary team to better the
care we offer our patients.
The difﬁculty in initial diagnosis arose from
the atypical patient demographic; a young
female smoker, which highlights the changing
presentation of Buerger’s disease. Our case
seems to reﬂect current population trends with a
higher proportion of smokers being women. It
has been reported that despite the higher preva-
lence of smoking in men, the difference in pro-
portions of smokers is less than previously
recorded; 3% more men (22%) smoked than
women (19%) in 2007 compared with 6% more
in the 1980s.
7
The prevention of initiation and progression of
Buerger’s disease is key. It is important to engage
and educate patients about smoking cessation,
including the conservative and pharmacological
options. The risk of amputation in patients with
Buerger’s can be reduced from 27% to 5% after
stopping smoking.
1
Amputation is an emotive subject and our
patients require both physical and psychological
preparation and support. For a young woman
facing amputation, the implications extend
further and include aspects of body image.
Several studies have looked at the effects of ampu-
tations and have demonstrated the need for early
and long-term multidisciplinary support using a
bio-psycho-social model.
8
The role of medical management in Buerger’s
disease is to try to prevent tissue loss. However,
these patients tend not to respond well to the
typical treatments, due to the narrowing and
thrombosis of their vessels. Endovascular repair
is not commonly used, and bypass operations
where diseased arteries are avoided as targets for
reconstruction can be performed. The outcome
of these have generally been reported as poor
with 41% primary graft patency at 1 year, 32% at
5 years, and 30% at 10 years postoperatively.
9
The diagnosis of Buerger’s disease remains dif-
ﬁcult due to the lack of speciﬁc clinical, radiologi-
cal and pathological ﬁndings, as well as lack of
internationally validated diagnostic criteria.
Recent advances in the treatment seem promis-
ing. The use of granulocyte colony-stimulating
factor-mobilized autologous mononuclear cells
resulted in a 79% one-year amputation-free rate,
and may be considered in patients unsuitable for
traditional revascularization.
10
This case has demonstrated the challenges in
diagnosis and treatment of Buerger’s disease in a
patient who has undergone a number of amputa-
tion operations. Through the application of a
holistic and individualized multidisciplinary
team approach, her independence has been
maintained.
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